• Register
  • Login

Iranian Journal of Pharmaceutical Sciences

  • Home
  • Journal Info
    • About the Journal
    • Aims and Scope
    • Editorial Team
    • Indexing & Abstracting
    • Privacy Statement
    • Contact us
  • Issues
    • Current
    • Archives
  • New Submissions
  • Author Guidelines
  • Policies & Process
    • Peer Review
    • Publication Ethics
    • Open Access Policy
    • Plagiarism
    • Retraction Policies
    • Archiving
  • Ethical Considration
Advanced Search
  1. Home
  2. Archives
  3. Vol. 19 No. 2 (2023): IJPS-Volume 19- Issue 2 (2023)
  4. Research/Original Articles

Vol. 19 No. 2 (2023)

April 2023

The Effect of Avena sativa L. Cream on Acute Radiation Dermatitis in Breast Cancer Patients Avena. sativa Cream on Skin Problems due to Radiotherapy

  • Mahnaz Antikchi
  • Shahrzad Ghiyasvandian
  • Farahnaz Farnia
  • Masood Shabani
  • Mohammad Kamalinejad

Iranian Journal of Pharmaceutical Sciences, Vol. 19 No. 2 (2023), 1 April 2023 , Page 99-109
https://doi.org/10.22037/ijps.v19i2.43803 Published: 2023-04-01

  • View Article
  • Download
  • Cite
  • References
  • Statastics
  • Share

Abstract

Based on estimates, the skin reactions caused by radiation therapy in women with breast cancer range from 87 to 96%. Since the purpose of complementary and alternative medicine in nursing care is to alleviate suffering and increase patient comfort, the researchers decided to evaluate the medicinal properties of Avena sativa L. and the effectiveness of Avena sativa L. cream on skin problems caused by radiation therapy in women with breast cancer. In this clinical trial, 66 patients with breast cancer were divided into two groups: the intervention and the control group. From the beginning to the end of the radiation therapy, the Intervention group was treated with creams containing extracts of Avena sativa L.  applied locally and three times a day, and the control group used cream lacking Avena sativa L. extract. The degree of skin problems, erythema, and dry and moist desquamation in the special intervals in both groups were evaluated. The study results revealed no significant difference in the degree of radio dermatitis in both groups. However, clinically, the incidence of dry desquamation in the intervention group is lower than in the control group but statistically insignificant. There was no significant difference between the two groups with moist desquamation and mild and bright erythema incidence. Conclusion: The results showed that local products made with Avena sativa L. extract can be used in radiation-induced skin reactions such as dry desquamation, and it is very effective. Therefore, further studies with larger sample sizes are recommended to prove this.

Keywords:
  • Avena sativa L.
  • Breast cancer
  • Desquamation
  • Erythema
  • Radiation therapy
  • Skin problems
  • IJPS_Volume 19_ Issue 2- Pages 99-109

How to Cite

Antikchi, M., Ghiyasvandian, S., Farnia, F., Shabani, M., & Kamalinejad, M. (2023). The Effect of Avena sativa L. Cream on Acute Radiation Dermatitis in Breast Cancer Patients: Avena. sativa Cream on Skin Problems due to Radiotherapy. Iranian Journal of Pharmaceutical Sciences, 19(2), 99–109. https://doi.org/10.22037/ijps.v19i2.43803
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

References

Prock D and Kristjanson L. Skin reactions during radiotherapy for breast cancer: the use and impact of topical agents and dressing. Eur J Cancer Care. 1999,8: 143-153.

Mcquestion M. Evidence- Based Skin Care Management in Radiation Therapy. Seminars in Oncology Nursing, .2006. 22(3). 163–173

Rafati M, Ghasemi A, Saeedi M, Habibi E, Salehifar E, Mosazadeh M, et al. Nigella sativa L. for prevention of acute radiation dermatitis in breast cancer: A randomized, double-blind, placebo-controlled, clinical trial. Complementary therapies in medicine. 2019;47:102205.

Omidvari, S., A. Shafizad, et al. (2011). "Efficacy of Topical Honey, Topical Hydrocortisone 1% and Simple Washing on Healing of Radiation-induced Dermatitis in Breast Cancer Patients." Journal of Isfahan Medical School 28(114).828-836.

Hasan, S. S., S. I. Ahmed, et al. (2009). "Use of complementary and alternative medicine among patients with chronic diseases at outpatient clinics." Complementary therapies in clinical practice 15(3): 152-157.

Ebrahimi SM, Parsa-Yekta Z, Nikbakht-Nasrabadi A, Salehi-Surmaghi MH & et al.Ginger effects on control of chemotherapy induced nausea and vomiting. Tehran Univ Med J (TUMJ). 2013. 71(6):395-403.

FENG, B., MA, L.-J., YAO, J.-J., FANG, Y., MEI, Y.-A. & WEI, S.-M. Protective effect of oat bran extracts on human dermal fibroblast injury induced by hydrogen peroxide. Journal of Zhejiang University SCIENCE B, . 2013.14, 97-105.

Singh, M., et al., Radiodermatitis: a review of our current understanding. American journal of clinical dermatology, 2016. 17: p. 277-292.

Burke G, Faithfull S, Probst H. Radiation induced skin reactions during and following radiotherapy: A systematic review of interventions. Radiography 28 (2022) 232-239

Nasser NJ, Fenig S, Ravid A, Nouriel A, Ozery N, Gardyn S, et al. Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients. NPJ breast cancer. 2017;3(1):10.

Nabi-Meybodi M, Sahebnasagh A, Hakimi Z, Shabani M, Shakeri AA, Saghafi F. Effects of topical timolol for the prevention of radiation-induced dermatitis in breast cancer: a pilot triple-blind, placebo-controlled trial. BMC cancer. 2022;22(1):1079.

Hindley A, Zain Z, Wood L, Whitehead A, Sanneh A, Barber D, et al. Mometasone furoate cream reduces acute radiation dermatitis in patients receiving breast radiation therapy: results of a randomized trial. International Journal of Radiation Oncology* Biology* Physics. 2014;90(4):748-55.

Ho AY, Olm-Shipman M, Zhang Z, Siu CT, Wilgucki M, Phung A, et al. A randomized trial of mometasone furoate 0.1% to reduce high-grade acute radiation dermatitis in breast cancer patients receiving postmastectomy radiation. International Journal of Radiation Oncology* Biology* Physics. 2018;101(2):325-33.

Sunku, R., A. K. Kalita, et al. (2021). "Effect of corticosteroid ointment on radiation induced dermatitis in head and neck cancer patients: A prospective study." Indian Journal of Cancer 58(1): 69-75.

Karbasforooshan H, Hosseini S, Elyasi S, Fani Pakdel A, Karimi G. Topical silymarin administration for prevention of acute radiodermatitis in breast cancer patients: A randomized, double‐blind, placebo‐controlled clinical trial. Phytotherapy research. 2019;33(2):379-86.

Menon A, Prem SS, Kumari R. Topical betamethasone valerate as a prophylactic agent to prevent acute radiation dermatitis in head and neck malignancies: a randomized, open-label, phase 3 trial. International Journal of Radiation Oncology* Biology* Physics. 2021;109(1):151-60.

Farhan F, Kazemian A, Alagheband H. A double blind randomized trial to evaluation of topical betamethasone. Radiother Oncol. 2004; 25:38-41.

Ebrahimi SM, Parsa-Yekta Z, Nikbakht-Nasrabadi A, Hosseini SM, Sedighi S, Salehi-Surmaghi M-H. Ginger effects on control of chemotherapy induced nausea and vomiting. Tehran University Medical Journal. 2013;71(6).

Putri IPN, Prajoko YW, Prihharsanti CHN, Sadhana U, Susilaningsih N. Topical Role of Ozonated Aloe vera Oil in Radiation Dermatitis: Expression of TGF-β and Collagen Density. Open Access Macedonian Journal of Medical Sciences (OAMJMS). 2022;10(E):1004-11.

Rafati M, Ghasemi A, Saeedi M, Habibi E, Salehifar E, Mosazadeh M, et al. Nigella sativa L. for prevention of acute radiation dermatitis in breast cancer: A randomized, double-blind, placebo-controlled, clinical trial. Complementary therapies in medicine. 2019; 47:102205.

  • Abstract Viewed: 662 times
  • IJPS_Volume 19_ Issue 2- Pages 99-109 Downloaded: 410 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Developed By

Open Journal Systems

Information

  • For Readers
  • For Authors
  • For Librarians
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact

Creative Commons License
This journal (and its contents) is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Print ISSN: 1735-2444

Online ISSN: 2252-0457

Powered by OJSPlus